Research Interests

Primary Ciliary Dyskinesia, Bronchiectasis, Motile ciliopathy

Prof Amelia Shoemark is Asthma and Lung UK Chair of Respiratory Research at the Universoty of Dundee. Her translational research program aims to target ciliary dysfunction as a therapeutic strategy in chronic lung disease. 

Prof Shoemark completed her PhD in respiratory medicine at the National, Heart and Lung Institute, Imperial College London. Her PhD work investigated inflammation in the lungs of patients with the chronic respiratory condition bronchiectasis helping to define causes of the disease (http://www.nhs.uk/conditions/bronchiectasis/).

In her role as lead clinical scientist at the Royal Brompton Hospital Amelia developed a specialist interest in an inherited cause of bronchiectasis, Primary Ciliary Dyskinesia (PCD). She set up and led a nationally funded laboratory for the diagnosis of Primary Ciliary Dyskinesia from 2007-2017, a position she still holds part time. 

Prof Shoemark is chair of the European Respiratory Society Clinical Research collaboration BEAT-PCD (beat-pcd.squarespace.com)and work package lead in the EMBARC European Bronchiectasis Registry, a pan-European network committed to promoting clinical research and education in bronchiectasis (https://www.bronchiectasis.eu/)